Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extension

Overweight and obesity are common among patients with Cushing's syndrome (CS) and may persist in some patients even after ostensibly curative surgery, contributing to cardiometabolic dysfunction and increased cardiovascular risk. Mifepristone, a selective glucocorticoid receptor antagonist, was...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	BMC endocrine disorders 2015-10, Vol.15 (1), p.63-63, Article 63
Hauptverfasser:	Fein, Henry G, Vaughan, 3rd, T Brooks, Kushner, Harvey, Cram, David, Nguyen, Dat
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Cushing Syndrome - drug therapy Female Follow-Up Studies Hormone Antagonists - therapeutic use Humans Male Middle Aged Mifepristone - therapeutic use Prognosis Receptors, Glucocorticoid - antagonists & inhibitors Time Factors Weight Loss - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!